RECENT GUIDANCE ON THE USE OF GLP-1 RAs IN PATIENTS WITH T2D In consideration of recently reported cardiovascular and renal outcome data, multiple organizations have published updated guidance over the last several years regarding the use of glucose-lowering agents in patients with T2D to mitigate cardiovascular and renal risks
Novo Nordisk launched Ozempic (semaglutide injection) in India in December 2025
While there is no standardized settlement amount, the anticipated range for serious injuries is expected to be between $400,000 and $700,000
Wade and Salo-Ahen, 2019)
Qi Z, Stephens NR, Spalding EP (2006) Calcium entry mediated by GLR3.3, an Arabidopsis glutamate receptor with a broad agonist profile
PreetiGlo L-Glutathione, Vitamin C, Alpha Lipoic Acid, Grape Seed Extract & Vitamin E Skin Brightening Tablets.